Advertisement

Topics

MorphoSys readies filing after positive Phase 2 lymphoma data

05:57 EDT 14 Mar 2018 | BioPharmaDive

Promising mid-stage data in a hard-to-treat patient population has prompted the biotech to seek FDA approval early and begin commercialization plans.

Original Article: MorphoSys readies filing after positive Phase 2 lymphoma data

NEXT ARTICLE

More From BioPortfolio on "MorphoSys readies filing after positive Phase 2 lymphoma data"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...